Tuberculosis Disease: Treatment and Side Effects

Azer KILIÇ BAŞKANa , Fazilet KARAKOÇb

aİstanbul University-Cerrahpaşa, Cerrahpaşa Faculty of Medicine, Department of Pediatric Chest Diseases, İstanbul, Türkiye
bMarmara University Faculty of Medicine, Department of Pediatric Chest Diseases, İstanbul, Türkiye

ABSTRACT
Childhood TB is still among the leading causes of mortality and morbidity due to the treatment decisions and difficulties in its implementation. Treatment of tuberculosis in children usually includes first-line drugs such as isoniazid, rifampicin, pyrazinamide, and ethambutol unless drug resistance is suspected. Adverse drug reactions are among the most critical factors affecting treatment compliance during TB treatment. Early identification and management of these adverse effects is critical to optimizing the successful completion of therapy.
Keywords: Child; drug-related side effects and adverse reactions; tuberculosis

Referanslar

  1. Lewinsohn DM, Leonard MK, LoBue PA, et al. Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention Clinical Practice Guidelines: Diagnosis of Tuberculosis in Adults and Children. Clin Infect Dis. 2017;64(2):111-5. [Crossref]
  2. World Health Organization. Global Tuberculosis Report 2022. Geneva: World && Health Organisation; 2022.
  3. World Health Organization. WHO consolidated guidelines on tuberculosis & Module 5: Management of tuberculosis in children and adolescents. Geneva: World Health Organisation; 2022.
  4. Ozcelik U, Kocabas E, Ersu R, Gurkan F, Cakır E, Karakoc F, et al. Tuberculosis in childhood. Turkish Thoracic Society Thoracic Books No: 23. 2017;7:1-153.
  5. Jaganath D, Beaudry J, Salazar-Austin N. Tuberculosis in Children. Infect Dis Clin North Am. 2022;36(1):49-71. [Crossref]  [PubMed]  [PMC]
  6. Furin J, Cox H, Pai M. Tuberculosis. Lancet. 2019;393(10181):1642-56. [Crossref]  [PubMed]
  7. Ramachhandran G, Kumar AK, Swaminathan S. Pharmacokinetics of anti-tuberculosis drugs in children. Indian J Pediatr. 2011;78(4):435-42. [Crossref]  [PubMed]
  8. Republic of Turkey Ministry of Health (2011). Republic of Turkey Ministry of Health tuberculosis diagnosis and treatment guideline. Accessed: 27 December 2020.
  9. Zhang HY, Ehiri J, Yang H, Tang S, Li Y. Impact of Community-Based DOT on Tuberculosis Treatment Outcomes: A Systematic Review and Meta-Analysis. PLoS One. 2016;11(2):e0147744. [Crossref]  [PubMed]  [PMC]
  10. Finlayson H, Lishman J, Palmer M. What's new in childhood tuberculosis. Curr Opin Pediatr. 2023;35(2):166-75. [Crossref]  [PubMed]
  11. Chabala C, Turkova A, Thomason MJ, et al. Shorter treatment for minimal tuberculosis (TB) in children (SHINE): a study protocol for a randomized controlled trial. Trials. 2018;19:237. [Crossref]  [PubMed]  [PMC]
  12. Turkova A, Wills GH, Wobudeya E, et al. Shorter treatment for nonsevere & tuberculosis in African and Indian children. N Engl J Med. 2022;386:911-22. [Crossref]  [PubMed]  [PMC]
  13. Maphalle LNF, Michniak-Kohn BB, Ogunrombi MO, Adeleke OA. Pediatric Tuberculosis Management: A Global Challenge or Breakthrough? Children(Basel). 2022;9(8):1120. [Crossref]  [PubMed]  [PMC]
  14. Schaaf HS, Garcia-Prats AJ, Donald PR. Antituberculosis drugs in children. Clin Pharmacol Ther. 2015;98(3):252-65. [Crossref]  [PubMed]
  15. Principi N, Italian Pediatric TB Study Group, Galli L, Lancella L, Tadolini M, Migliori GB, Villani A, Esposito S. Recommendations concerning the first-line treatment of children with tuberculosis. Paediatr Drugs. 2016;18(1):13-23. [Crossref]  [PubMed]
  16. Rapid Advice: Treatment of Tuberculosis in Children. Geneva: World Health Organization; 2010. WHO Guidelines Approved by the Guidelines Review Committee. Bookshelf ID: NBK310339 [PubMed]
  17. Pelosi U, Pintus R, Savasta S, Fanos V. Pulmonary Tuberculosis in Children: A Forgotten Disease? Microorganisms. 2023;11(7):1722. [Crossref]  [PubMed]  [PMC]
  18. American Academy of Pediatrics. Committee on Infectious Diseases. RedBook: Report of the Committee on Infectious Diseases, 30th ed. AAP: Elk Grove Village, IL, USA: 2015.
  19. Lin MY, Lin SJ, Chan LC, Lu YC. Impact of food and antacids on the pharmacokinetics of anti-tuberculosis drugs: systematic review and meta-analysis. Int J Tuberc Lung Dis. 2010;14(7):806-18.
  20. Li Yiyuan, Zhu Y, Zhong Q, Zhang X, Shu M, Wan C. Serious Adverse Reactions From Anti-tuberculosis Drugs Among 599 Children Hospitalized for Tuberculosis. Pediatr Infect Dis J. 2017;36(8):720-5. [Crossref]  [PubMed]